Product Information
EDARBI 80 MG TABLET is a brand product labeled by Azurity Pharmaceuticals Inc., priced at $9.0031 per EA under NDC 60631008030. Its NADAC has been published 595 times since Feb 4, 2015.
Strength
80 mg/1
Manufacturer
Azurity Pharmaceuticals Inc.NDC
60631008030
Classification
Brand
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
AZILSARTAN KAMEDOXOMILApproval Type
New Drug (NDA)
FDA Application
NDA200796On Market Since
2/1/2013
Pharmacological Classes
Price Statistics
The NADAC for EDARBI 80 MG TABLET has been published 595 times since Feb 4, 2015, and over the history we have for it it has risen 105.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $9.0031 per EA |
|---|---|
| All-time high | $9.0061 (May 14, 2025) |
| All-time low | $4.3773 (Feb 4, 2015) |
| 52-week high | $9.0031 |
| 52-week low | $8.9853 |
| Median price | $6.8354 |
| Average price | $6.9343 |
| Largest weekly change | +10.0% (Feb 11, 2015) |
| Weeks tracked | 595 |
| Tracking since | Feb 4, 2015 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Azilsartan kamedoxomil market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of EDARBI 80 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for EDARBI 80 MG TABLET, manufactured by Azurity Pharmaceuticals Inc., is $9.0031 per EA (NDC 60631008030), effective Jun 24, 2026.
How has the price of EDARBI 80 MG TABLET changed over time?
Over the history we have for it, the NADAC for EDARBI 80 MG TABLET has risen 105.7%. It has been tracked across 595 weekly CMS publications since Feb 4, 2015.
What are the highest and lowest recorded NADAC prices for EDARBI 80 MG TABLET?
Since Feb 4, 2015, the NADAC for EDARBI 80 MG TABLET has ranged from a low of $4.3773 (Feb 4, 2015) to a high of $9.0061 (May 14, 2025), with a median of $6.8354 per EA.
Are there cheaper alternatives to EDARBI 80 MG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of EDARBI 80 MG TABLET, so no direct lower-cost alternative is listed.
Who manufactures EDARBI 80 MG TABLET?
EDARBI 80 MG TABLET (NDC 60631008030) is labeled by Azurity Pharmaceuticals Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification